Targeting vaccinia to solid tumors with local hyperthermia

T-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccine

Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus

Selective gene transfer to tumor cells by recombinant Newcastle Disease Virus via a bispecific fusion protein

Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer

Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells

Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit

High cell surface expression of Newcastle disease virus proteins via replicon vectors demonstrates syncytia forming activity of F and fusion promotion activity of HN molecules

Importance of serine 200 for functional activities of the hemagglutinin-neuraminidase protein of Newcastle Disease Virus